Technical Analysis for BGNE - BeiGene, Ltd.

Grade Last Price % Change Price Change
grade B 125.82 1.20% 1.49
BGNE closed up 1.2 percent on Tuesday, November 20, 2018, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical BGNE trend table...

Date Alert Name Type % Chg
Nov 20 20 DMA Support Bullish 0.00%
Nov 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.94%
Nov 16 Pocket Pivot Bullish Swing Setup -0.94%
Nov 16 Narrow Range Bar Range Contraction -0.94%
Nov 16 NR7 Range Contraction -0.94%
Nov 16 NR7-2 Range Contraction -0.94%
Nov 16 Inside Day Range Contraction -0.94%
Nov 16 Up 3 Days in a Row Strength -0.94%
Nov 16 Up 4 Days in a Row Strength -0.94%
Nov 15 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.93%

Older signals for BGNE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
BeiGene, Ltd., a clinical-stage biopharmaceutical company, discovers and develops various oncology drugs in the People's Republic of China. The company's clinical stage drug candidates include BGB-3111, a small molecule BTK inhibitor for the treatment of various lymphomas; BGB-283, a small molecule RAF dimer inhibitor to treat cancers with aberrations in the mitogen-activated protein kinase pathway, including BRAF mutations and KRAS/NRAS gene mutations; BGB-290, an inhibitor of PARP1 and PARP2 for the treatment of homologous recombination deficient cancers; and BGB-A317, a humanized monoclonal antibody for solid-organ and blood-borne cancers. Its preclinical programs comprise a PD-L1 monoclonal antibody, an additional RAF dimer inhibitor, a TIM-3 cell surface protein monoclonal antibody, and a BTK inhibitor for non-oncology indications. The company was founded in 2010 and is based in Camana Bay, Cayman Islands.
Is BGNE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 220.1
52 Week Low 77.54
Average Volume 420,208
200-Day Moving Average 160.9111
50-Day Moving Average 138.5486
20-Day Moving Average 120.715
10-Day Moving Average 122.492
Average True Range 7.6478
ADX 22.27
+DI 18.9406
-DI 23.7128
Chandelier Exit (Long, 3 ATRs ) 114.4566
Chandelier Exit (Short, 3 ATRs ) 128.1334
Upper Bollinger Band 134.9378
Lower Bollinger Band 106.4922
Percent B (%b) 0.68
BandWidth 23.564263
MACD Line -2.9885
MACD Signal Line -4.9771
MACD Histogram 1.9885
Fundamentals Value
Market Cap 5.01 Billion
Num Shares 39.8 Million
EPS -4.97
Price-to-Earnings (P/E) Ratio -25.32
Price-to-Sales 0.00
Price-to-Book 12.46
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 135.93
Resistance 3 (R3) 135.22 131.13 134.25
Resistance 2 (R2) 131.13 128.56 131.49 133.68
Resistance 1 (R1) 128.48 126.97 129.81 129.19 133.12
Pivot Point 124.39 124.39 125.06 124.75 124.39
Support 1 (S1) 121.74 121.82 123.07 122.45 118.52
Support 2 (S2) 117.65 120.23 118.01 117.96
Support 3 (S3) 115.00 117.65 117.40
Support 4 (S4) 115.71